Bioxyne Limited (BXN.AX)

0.0080 -0.0010 (-11.11%) At close: 03:25PM AEST

Bioxyne Limited

50 Clarence Street
Suite 506 Level 5
Sydney, NSW 2000
Australia
61 2 9078 7669
https://bioxyne.com

Sector(s): Consumer Defensive
Industry: Packaged Foods
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Samuel Watson	CEO, MD & Executive Director	215.82k	N/A	N/A
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD	CFO & Company Secretary	98.5k	N/A	1953
Mr. Jason Hine	COO & Executive Director	319.27k	N/A	N/A
Ms. Rachel Qian	Financial Controller & Assistant Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Bioxyne Limited, a life sciences and consumer health products company, manufactures and distributes consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines in the United Kingdom, Japan, Europe, and Australia. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, vitamins, manuka honey, skin care products, and mushroom complexes. It develops various functional food products, such as ingredients; and lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. The company also provides product research and development services, and telemedicine services. In addition, it operates BLS Clinics, a telehealth platform. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.

Corporate governance

Bioxyne Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.